SEMNUR PHARMACEUTICALS INC has a total of 33 patent applications. It increased the IP activity by 50.0%. Its first patent ever was published in 2014. It filed its patents most often in United States, Australia and Hong Kong. Its main competitors in its focus markets pharmaceuticals are TILTAN PHARMA LTD, COLUMBIA LABORATORIES BERMUDA LTD and M et P Pharma AG.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 6 | |
#2 | Australia | 3 | |
#3 | Hong Kong | 3 | |
#4 | Taiwan | 3 | |
#5 | Brazil | 2 | |
#6 | Canada | 2 | |
#7 | China | 2 | |
#8 | EPO (European Patent Office) | 2 | |
#9 | Israel | 2 | |
#10 | Republic of Korea | 2 | |
#11 | Mexico | 2 | |
#12 | WIPO (World Intellectual Property Organization) | 2 | |
#13 | Japan | 1 | |
#14 | New Zealand | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations |
# | Name | Total Patents |
---|---|---|
#1 | Shah Mahendra G | 26 |
#2 | Mahendra G Shah | 3 |
#3 | Shah Mahendra G G | 1 |
#4 | Shah Mahendra | 1 |
Publication | Filing date | Title |
---|---|---|
TW201630609A | Pharmaceutical formulation | |
AU2014209346A1 | Pharmaceutical formulation comprising an insoluble corticosteroid and a soluble corticosteroid |